SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a foc ...

Investing.com -- Structure Therapeutics Inc ADR (NASDAQ:GPCR) stock soared 28.8% in premarket trading Monday after the company announced positive topline data from its ACCESS clinical program for ...

In the GenAI era, program comprehension is not just another skill in the toolbox; it is the toolbox itself. It enables learners to move beyond passive acceptance of AI outputs, guiding them to ...

The latest announcement is out from Ascelia Pharma AB ( (SE:ACE) ).

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools ...

Organizations may need to share their data to achieve business goals. Here’s how they can do it with compliance in mind.

In a major step toward a precision therapy for Clostridioides difficile (C. diff) infection, researchers at The Hospital for ...

DLR, Airbus Helicopters, Fraunhofer and TU Dresden work in the NATURE project for environmentally friendly aviation ...

This report studies the pricing of negatively elevated structures in the National Flood Insurance Program. Current NFIP methods for calculating risk-based premiums for these structures, including risk ...

A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial proteomics and lipidomics easier to use – no coding required. C-COMPASS ...

Initial favorable safety profile demonstrated in OPGx-BEST1 clinical trialRESEARCH TRIANGLE PARK, N.C., Dec. 09, 2025 (GLOBE ...

In a major step towards a precision therapy for Clostridioides difficile (C. diff) infection, researchers at The Hospital for ...